Neuromuscular Changes In Small For Gestational Age Children During Somatropin Therapy

PHASE3

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped The study terminated on 19-Jan-2011 due to insufficient recruitment of patients. No safety reasons contributed to the termination of the study.

Conditions

Growth Hormone Therapy
Infant, Small for Gestational Age

Interventions

DRUG: Somatropin
DRUG: Somatropin

Sponsor

Pfizer